Armstrong Advisory Group’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.2K | Sell |
32
-24
| -43% | -$10.7K | ﹤0.01% | 597 |
|
|
2025
Q1 | $22.6K | Hold |
56
| – | – | ﹤0.01% | 494 |
|
|
2024
Q4 | $22.6K | Hold |
56
| – | – | ﹤0.01% | 494 |
|
|
2024
Q3 | $26K | Sell |
56
-41
| -42% | -$19.1K | ﹤0.01% | 462 |
|
|
2024
Q2 | $45.5K | Buy |
97
+48
| +98% | +$22.5K | ﹤0.01% | 368 |
|
|
2024
Q1 | $19.9K | Hold |
49
| – | – | ﹤0.01% | 482 |
|
|
2023
Q4 | $19.9K | Hold |
49
| – | – | ﹤0.01% | 482 |
|
|
2023
Q3 | $17K | Hold |
49
| – | – | ﹤0.01% | 522 |
|
|
2023
Q2 | $17.2K | Sell |
49
-166
| -77% | -$58.4K | ﹤0.01% | 511 |
|
|
2023
Q1 | $67.7K | Buy |
215
+49
| +30% | +$15.4K | 0.01% | 281 |
|
|
2022
Q4 | $47.9K | Buy |
+166
| New | +$47.9K | 0.01% | 329 |
|